| Involvement of the Second Extracellular Loop (E2) of the Neurokinin-1 Receptor in the Binding of Substance P: PHOTOAFFINITY LABELING AND MODELING STUDIES* 210 O Lequin, G Bolbach, F Frank, O Convert, S Girault-Lagrange, ... Journal of Biological Chemistry 277 (25), 22386-22394, 2002 | 34 | 2002 |
| Cα methylation in molecular recognition: Application to substance P and the two neurokinin‐1 receptor binding sites S Sagan, O Lequin, F Frank, O Convert, M Ayoub, S Lavielle, ... European Journal of Biochemistry 268 (10), 2997-3005, 2001 | 13 | 2001 |
| Scientific integrity requires publishing rebuttals and retracting problematic papers J Barrière, F Frank, L Besançon, A Samuel, V Saada, E Billy, A Al-Ahmad, ... Stem Cell Reviews and Reports 19 (2), 568-572, 2023 | 7 | 2023 |
| Reply to “Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs”: Important concerns on the validity of this article. J Barriere, F FRANK, L Besançon, A Samuel, V Saada, E Billy, ... OSF, 0 | 4 | |
| Letter to Editor “Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs”: Important concerns on the validity of this … J Barrière, F Frank, L Besancon, A Samuel, V Saada, E Billy, A Al-Ahmad, ... Food and Chemical Toxicology 178, 113897, 2023 | 3 | 2023 |
| Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted D Barraud, L Besançon, EM Bik, E Billy, F Clarot, F Frank, A Guihur, ... Therapie, 2023 | 3 | 2023 |
| La lutte contre la fraude scientifique: une tâche ingrate mais nécessaire J Barrière, F Frank, L Besancon, A Samuel, V Saada, E Billy, ... Bull Cancer 109 (10), 996-98, 2022 | 2 | 2022 |
| VIRUS: Visualization of Irregular Research Under Scrutiny F Frank, L Besançon VIS 2024-IEEE Visualization Extended Abstracts, 2024 | | 2024 |
| Are we done with Hydroxychloroquine for COVID-19? Studies with ethical, legal, and methodological concerns must now be retracted F Frank, J Barriere, D Gorski, F Lemaitre, G Meyerowitz-Katz, M Mulot, ... OSF, 2023 | | 2023 |
| The fight against scientific fraud: A thankless but necessary task J Barriere, F Frank, L Besancon, A Samuel, V Saada, E Billy, ... Bulletin du Cancer, S0007-4551 (22) 00303, 2022 | | 2022 |
| Should we publish every correlation during the COVID-19 pandemic? N Florens, G Meyerowitz-Katz, J Barriere, E Billy, F FRANK, V Saada, ... OSF Preprints, 2022 | | 2022 |
| Covidiots et cancer. Y a-t-il une ânerie qu’ILS n’ont pas proférée? J Robert, F Frank, L Besançon, A Samuel, V Saada, É Billy, B Seitz-Polski, ... Innovations & Thérapeutiques en Oncologie 8 (4), 179-181, 2022 | | 2022 |
| PROTEIN STRUCTURE AND FOLDING-Involvement of the second extracellular loop (E2) of the neurokinin-1 receptor in the binding of substance P. Photoaffinity labeling and modeling … O Lequin, G Bolbach, F Frank, O Convert, S Girault-Lagrange, ... Journal of Biological Chemistry 277 (25), 22386-22394, 2002 | | 2002 |
| Cαmethylation in molecular recognition: Application to substance P and the two neurokininâ 1 receptor binding sites S Sagan, O Lequin, F Frank, O Convert, M Ayoub, S Lavielle | | 2001 |
| Conformation bioactive de la substance p et structure de la boucle e3 de son recepteur F Frank Paris 6, 1999 | | 1999 |
| When scientific journals disseminate pseudoscience J Barriere, F FRANK, L Besançon, A Samuel, V Saada, E Billy, ... OSF, 0 | | |
| Should a request for the retraction of a misleading article suggesting that mRNA anti SARS-CoV-2 vaccines may cause cancer be part of the scientific debate or be rejected? A … J Barriere, F FRANK, L Besançon, A Samuel, V Saada, E Billy, ... OSF, 0 | | |
| Issues with Ethics in Research–A Case Study of the IHU Mediterranee Infection F FRANK, N Florens, J Barriere, E Billy, V Saada, A Samuel, L Besançon OSF, 0 | | |
| Ca methylation in molecular recognition S Sagan, O Lequin, F Frank, O Convert, M Ayoub, S Lavielle, ... | | |
